Schedule 13G
RLAY Schedule 13G filing by Fidelity / FMR
Fidelity / FMR reported beneficial ownership of 20.0K shares, representing 9.4% of Relay Therapeutics, Inc. in this filing.
FiledAug 6, 2026
Ownership dateJun 30, 2026
Reported shares20.0K
Reported ownership9.4%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
20.0M
Shared voting power
0
Sole dispositive power
20.0K
Shared dispositive power
0
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$19.75as of Aug 6, 2026
Latest tracked price$19.69as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Fidelity / FMR
- CIK
- CIK0000315066
- Accession
- 0000315066-26-002113
- Form
- Schedule 13G
Read the filing in context